Navigation Links
X – Rays Found To Increase Cancer Risk

In a recent study researchers estimated the likely extent of the cancer risk based on the annual number of diagnostic X-rays undertaken in // various developed countries.

Investigators report the cumulative risk of cancer ranged from 0.6 percent to 1.8 percent to over 3 percent in Japan. Japan has the highest number of annual diagnostic X-rays in the world. In the United Kingdom, researchers say the risk of cancer was 0.6 percent. This suggests around 700 of the 124,000 cases of cancer diagnosed in the United Kingdom each year could be attributable to exposure to diagnostic X-rays. Researchers say their calculations depended on a number of assumptions, and so are inevitably subject to considerate uncertainty.

However researchers from Germany say the present study has not taken into account the benefit of the X-rays for the patients in their research. They say the earlier detection of cancer by radiological examinations and possibly earlier treatment could mean more cancers are cured. However, they agree that a general goal should be to avoid unnecessary X-ray procedures. For example, they point out that up to 30 percent of chest X-rays may not be necessary and doctors need to think carefully about the benefits for and the risk to their patients for each examination.
'"/>




Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rays Found Increase Cancer Risk

(Date:12/15/2009)... Accelify is proud to announce the addition ... David will serve as Director of Development in the ... Board of Advisors. ,, David Tokofsky was ... of Education in June 1995. As the Board Member ... 600,000 stretching from Northeast Los Angeles through East Los ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... released its latest research "The Future ...
(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...
(Date:12/15/2009)... Visits to a gynaecologist or midwife are generally ... but could offer so much more. Women, doctors ... great opportunities for dialogue about sexual health, reveals ... University of Gothenburg, Sweden. , Many young women ... Almost 500 women aged 23-29 answered questions about ...
(Date:12/15/2009)... seen as a potential heart disease therapy, raising high-density ... transfer protein may not be effective, a new study ... Research Center on Aging (USDA HNRCA) at Tufts University ... association between low plasma cholesterol ester transfer protein (CETP) ... Framingham Heart Study population. , CETP is a protein ...
Breaking Medicine News(10 mins):Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6Health News:More about sex and relationships needed at gynecological visits 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2
... ... Offering, LAKEWOOD, N.J., ... a national gastrointestinal (GI),offering to further expand its diagnostic services. The ... a regional laboratory into a national anatomic pathology leader,offering a range ...
... 19 Align Technology,Inc. (Nasdaq: ALGN ), today ... president of research and development, effective June 16. Mr. ... Officer, Thomas,M. Prescott and lead the Company,s research and ... and we are pleased to,have Dana on board to ...
... Minneapolis-St. Paul, DC and San,Francisco as Most Heart Friendly ... the No. 1,killer of women, may hit closer to ... Red For Women movement released a study,conducted by Sperling,s ... heart friendly cities for women. Minneapolis-St. Paul took the,title ...
... May 19 Chiltern, a leading global research,organization, announced ... of,General Manager, Latin America., The Latin American operation ... Podesta and will be primarily focused on supporting our,Global ... 9,years experience in clinical research, where he has held ...
... happen to men, not only to women, according to Group ... Domestic violence in men is under-studied and often hiddenmuch as ... Robert J. Reid, MD, PhD, an associate investigator at the ... to know theyre not alone. His findings confirm some common ...
... ... Defy Economic Downturn and Remind Policy Makers that AIDS is Still ... a Crisis at Home., NEW YORK, May ... and most successful AIDS Walk,ever held, setting a fundraising record even in the face of ...
Other Medicine News:Health News:Lakewood Pathology Launches National Gastroinestinal Diagnostic Services 2Health News:Align Technology Names Dana C. Cambra as VP, Research & Development 2Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 2Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 3Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 4Health News:American Heart Association Ranks America's Most Heart Friendly Cities for Women 5Health News:Chiltern Expands Its Global Reach to Latin America 2Health News:Men experience domestic violence, with health impact 2Health News:AIDS Walk New York Raises $7.05 Million 2
(Date:12/15/2009)... CITY, Dec. 15 Dynatronics ... signed a preferred vendor agreement to provide therapy ... Inc. (PTP), a nationwide network of physical, occupational ... be working with Preferred Therapy Providers," said Larry ... marketing at Dynatronics. "Their vast network of 1,100 ...
(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...
Breaking Medicine Technology:Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc. 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 1John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 2John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 3John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 4Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out of Pocket Costs Not Filling Prescriptions 49210 1New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out of Pocket Costs Not Filling Prescriptions 49210 2
Solid 15 mm blades with 8 mm narrowed portion. Screw-controlled locking mechanism with stabilizing disk. Dull finish....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Adult model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 14 mm....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Medicine Products: